Mesenchymal stem cells alleviate renal injury of lupus nephritis mice by reconstructing the immune microenvironment of renal tissue

Figure 2 Comparing the results of biochemical measurements changes to renal function, serum dsDNA and proteinuria levels. A: Schematic illustration of umbilical cord mesenchymal stem cells treatment in MRL/Lpr mice; B: Serum dsDNA level (U/mL); C: Urinary albumin/urinary creatinine ratio level (mg/mmoL); D: Blood urea nitrogen level (mmol/L); E: Serum creatinine level (μmol/L). All data was expressed as mean ± SEM, ^aP < 0.05 vs lupus nephritis group, ^bP < 0.01 vs lupus nephritis group, ^cP < 0.001 vs lupus nephritis group. LN: Lupus nephritis; UCMSCs: Umbilical cord mesenchymal stem cells; uALB: Urinary albumin; uCr: Urinary creatinine.